Proteome-informed machine learning studies of cocaine addiction
Cocaine addiction accounts for a large portion of substance use disorders and threatens millions of lives worldwide. There is an urgent need to come up with efficient anti-cocaine addiction drugs. Unfortunately, no medications have been approved by the Food and Drug Administration (FDA), despite the extensive effort in the past few decades. The main challenge is the intricate molecular mechanisms of cocaine addiction, involving synergistic interactions among proteins upstream and downstream of dopamine transporter (DAT) functions impacted by cocaine. However, traditional in vivo or in vitro experiments can not address the roles of so many proteins, highlighting the need for innovative strategies in the field. We propose a proteome-informed machine learning/deep learning (ML/DL) platform to discover nearly optimal anti-cocaine addiction lead compounds. We construct and analyze proteomic protein-protein interaction (PPI) networks for cocaine dependence to identify 141 involved drug targets and represent over 60,000 associated drug candidates or experimental drugs in the latent space using an autoencoder (EA) model trained from over 104 million molecules. We build 32 ML models for cross-target analysis of these drug candidates for side effects and repurposing potential. We further screen the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these candidates. Our platform reveals that essentially all of the existing drug candidates, including dozens of experimental drugs, fail to pass our cross-target and ADMET screenings. Nonetheless, we have identified two nearly optimal leads for further optimization.
Code (1)
Tasks
BIG-bench Machine LearningSimilar Papers 제목 키워드 기반
Machine learning analysis of cocaine addiction informed by DAT, SERT, and NET-based interactome networks
Cocaine addiction is a psychosocial disorder induced by the chronic use of cocaine and causes a large of number deaths around the world. Despite many decades' effort, no drugs have been approved by the Food and Drug Admi…
Drug DiscoveryMultiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing
The escalating drug addiction crisis in the United States underscores the urgent need for innovative therapeutic strategies. This study embarked on an innovative and rigorous strategy to unearth potential drug repurposin…
Drug DiscoveryTopological Data AnalysisChatGPT in Drug Discovery: A Case Study on Anti-Cocaine Addiction Drug Development with Chatbots
The birth of ChatGPT, a cutting-edge language model-based chatbot developed by OpenAI, ushered in a new era in AI. However, due to potential pitfalls, its role in rigorous scientific research is not clear yet. This paper…
ChatbotDrug DiscoveryLanguage ModelingLanguage ModellingOn the unknown proteins of eukaryotic proteomes
In order to study unknown proteins on a large scale, a reference system has been set up for the three major eukaryotic lineages, built with 36 proteomes as taxonomically diverse as possible. Proteins from 362 eukaryotic …
Addict Free -- A Smart and Connected Relapse Intervention Mobile App
It is widely acknowledged that addiction relapse is highly associated with spatial-temporal factors such as some specific places or time periods. Current studies suggest that those factors can be utilized for better rela…